Westley Timmerman

Westley Timmerman

Auto-generated profile, based on publicly available information

Westley Timmerman

Preclinical Research Center, Department of Surgery, University of Minnesota, Minneapolis, MN, USA

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2026 in American Journal of Transplantation
Verified
Journal Article
Open access
CMCole W. Myers
Cole W. Myers
CECheyenna Espinoza
Cheyenna Espinoza
SJScott Hunter Oppler Jr
Scott Hunter Oppler Jr
WTWestley Timmerman
Westley Timmerman
SPSydney Phu
Sydney Phu
Melanie L. GrahamMelanie L. Graham
Melanie L. Graham
Weight change predicts mortality and graft loss in human kidney transplant recipients, yet post-transplant weight dynamics in nonhuman primate (NHP) transplant models remain poorly characterized despite their importance in preclinical immunosuppression and tolerance studies. By failing to account for demographic-specific growth patterns, static weight thresholds reduce interpretability and mask early biological signals of post-transplant morbidity. We analyzed 879 weights from 40 NHPs undergoing allogeneic kidney transplantation, with follow-up censored at 1-year post transplant. Expected post-transplant trajectories were estimated using demographic-stratified linear mixed-effects models with natural splines. Deviations from predicted trajectories defined pathologic weight loss. Associations with adverse events were evaluated using time-dependent cause-specific Cox regression. Expected trajectories differed significantly by age and species, with greater anticipated weight gain among younger animals. Each one-standard deviation decrease below predicted weight was associated with a two-fold increased hazard of adverse events. The model predicted pathological deviations before symptom onset and humane endpoints. Longitudinal weight trajectory modeling represents a computational modeling-based new approach methodology (NAM) that improves interpretability of preclinical weight endpoints. Defining risk relative to expected trends enables earlier and more precise prediction of adverse events, supports adaptive intervention including immunosuppression de-escalation and infection-directed management.